Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2013

Numerex Corp. (NMRX) Starts Presentation at 25th Annual ROTH Conference

Numerex provides interactive and on-demand machine-to-machine (M2M) technology and services on a subscription basis, available for enterprise and government markets worldwide. NMRX offers Numerex DNA® that may include hardware and smart Devices, cellular and satellite Network services, and software Applications … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

QuickLogic Corp. (QUIK) Starts Presentation at 25th Annual ROTH Conference

QuickLogic is the inventor and pioneer of innovative, customizable semiconductor solutions for mobile and portable electronics OEMs and ODMs. These silicon plus software solutions are called Customer Specific Standard Products (CSSPs). CSSPs enable QUICK customers to bring their products to market … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Chelsea Therapeutics International Ltd. (CHTP) Starts Presentation at 25th Annual ROTH Conference

Chelsea Therapeutics International is a biopharmaceutical company engaged in acquiring and developing innovative products to treat a variety of human diseases, including disorders of the central nervous system. The company is presently pursuing FDA approval in the United States for … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Radiant Logistics, Inc. (RLGT) Starts Presentation at 25th Annual ROTH Conference

Radiant Logistics is a non-asset based transportation and logistics services company providing customers domestic and international freight forwarding services through a network of company-owned and independent agent offices operating under the Radiant, Airgroup, Adcom and DBA brands. RLGT also offers … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Atossa Genetics, Inc. (ATOS) Starts Presentation at 25th Annual ROTH Conference

Atossa Genetics known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to eight years before mammography. The … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

UniTek Global Services, Inc. (UNTK) Starts Presentation at 25th Annual ROTH Conference

UniTek Global Services provides engineering, construction management and installation fulfillment services to companies specializing in the telecommunications, broadband cable, wireless, two-way radio, transportation, public safety and satellite industries. The company has created a scalable operating platform, enabling each UNTK subsidiary … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

ARRIS Group, Inc. (ARRS) Starts Presentation at 25th Annual ROTH Conference

ARRIS Group is a worldwide communications technology company focused on designing, engineering and supplying communications and IP technologies that support broadband services for residential and business customers across the globe. The company provides broadband operators with the tools and platforms … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

MoSys, Inc. (MOSY) Starts Presentation at 25th Annual ROTH Conference

MoSys is an IP-rich fabless semiconductor company providing intelligent data access in network and communications systems. MOSY’s Bandwidth Engine® family of ICs combines the company’s patented 1T-SRAM® high-density, embedded memory and high-speed, 10 Gigabits per second serial interface with its … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Chembio Diagnostics, Inc. (CEMI) Starts Presentation at 25th Annual ROTH Conference

Chembio Diagnostics is a leading developer, manufacturer, licensor and marketer of point-of-care rapid diagnostic tests. The company’s two FDA PMA-approved, CLIA-waived rapid HIV tests are marketed in the United States by Alere, Inc., and the company markets its HIV STAT-PAK … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment

Repros Therapeutics, Inc. (RPRX) Starts Presentation at 25th Annual ROTH Conference

Repros Therapeutics develops products and services for the management of reproductive health. The company’s products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. RPRX focuses on … Continue reading

Posted in ROTH Capital Partners Conference | Leave a comment